Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial

Lucy X Ma, Emma Titmuss, Jonathan M Loree, Derek J Jonker, Hagen F Kennecke, Scott Berry, Felix Couture, Chaudhary E Ahmad, John R Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoit Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Sheryl Koski, Dongsheng Tu, Christopher O’Callaghan, Eric X Chen

Open source

DOI: 10.1136/jitc-2024-010094
Published: 2024-12
Container: Journal for ImmunoTherapy of Cancer
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2024-010094,
  title = {Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial},
  author = {Lucy X Ma and Emma Titmuss and Jonathan M Loree and Derek J Jonker and Hagen F Kennecke and Scott Berry and Felix Couture and Chaudhary E Ahmad and John R Goffin and Petr Kavan and Mohammed Harb and Bruce Colwell and Setareh Samimi and Benoit Samson and Tahir Abbas and Nathalie Aucoin and Francine Aubin and Sheryl Koski and Dongsheng Tu and Christopher O’Callaghan and Eric X Chen},
  year = {2024},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2024-010094},
  url = {https://doi.org/10.1136/jitc-2024-010094}
}

RIS

TY  - JOUR
TI  - Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial
AU  - Lucy X Ma
AU  - Emma Titmuss
AU  - Jonathan M Loree
AU  - Derek J Jonker
AU  - Hagen F Kennecke
AU  - Scott Berry
AU  - Felix Couture
AU  - Chaudhary E Ahmad
AU  - John R Goffin
AU  - Petr Kavan
AU  - Mohammed Harb
AU  - Bruce Colwell
AU  - Setareh Samimi
AU  - Benoit Samson
AU  - Tahir Abbas
AU  - Nathalie Aucoin
AU  - Francine Aubin
AU  - Sheryl Koski
AU  - Dongsheng Tu
AU  - Christopher O’Callaghan
AU  - Eric X Chen
PY  - 2024
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2024-010094
UR  - https://doi.org/10.1136/jitc-2024-010094
ER  -

APA

Ma, L. X., Titmuss, E., Loree, J. M., Jonker, D. J., Kennecke, H. F., Berry, S., Couture, F., Ahmad, C. E., Goffin, J. R., Kavan, P., Harb, M., Colwell, B., Samimi, S., Samson, B., Abbas, T., Aucoin, N., Aubin, F., Koski, S., Tu, D., O’Callaghan, C., & Chen, E. X. (2024). Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-010094

Source records

crossref · retrieved 2026-11-10T16:27:30.512Z